Asherman's Syndrome occurs when scar tissue forms inside the uterus, thereby leading to light periods, infertility, or recurrent miscarriages. This article explains its causes, symptoms, diagnosis, and treatment through hysteroscopy and hormonal care. Early detection and proper management significantly improve fertility outcomes as well as support healthier reproductive planning.
Asherman's Syndrome is a condition where scar tissue forms inside the uterus. This causes the uterine walls to stick together. It can disrupt normal menstrual flow as well as interfere with a woman’s ability to conceive. This condition develops in women after surgical procedures involving the uterus, especially in cases of incomplete healing. Although it may not come into attention for years, symptoms like light periods, pelvic pain, or infertility often prompt women to seek medical help.
Asherman's Syndrome is also known as intrauterine synechia. It’s the formation of scar tissue inside the uterine cavity. This scar tissue can partially or completely block the uterus. This inhibits the menstrual flow and reduces the available space for the implantation of an embryo. In many cases, women may not experience noticeable symptoms until they face difficulties conceiving or notice irregular menstrual cycles.
Those suffering from Asherman Syndrome may encounter infertility, recurrent pregnancy loss, or complications during pregnancy. This happens because the uterus functions abnormally. This is most often found in women with a history of uterine surgeries, infections, or trauma. If Asherman's syndrome is diagnosed early and treated with modern hysteroscopic technology, most women will recover normal uterine functioning and have a better chance of healthy conception.
Also Read : What are Types of ART Techniques?
Common causes of scar tissue in uterus include:
Common symptoms of intrauterine synechiae include:
In order to correctly diagnose the condition known as Asherman syndrome, medical professionals will collect information based on what occurred in the patient’s past, as well as how the patient is responding now, both medically and psychologically, to any symptoms that accompany this disorder. A common method used by physicians in determining whether a woman has Asherman syndrome is through hysteroscopy, where the physician can actually see any type of scarring that may have developed in the uterus.
Other diagnostic tests available to help determine whether or not a patient has this condition include:
Treatment focuses on restoring the uterine cavity, removing scar tissue, and supporting healthy endometrial growth. The primary treatment is hysteroscopic surgery, where scar tissue is carefully cut and removed using minimally invasive tools. This helps reopen the uterine cavity and improve menstrual flow.
Treatment options include:
Scar tissue that forms in the uterus can have a significant negative impact on fertility. It can hinder the implantation of embryos and decrease blood flow to the uterine lining. It makes the uterine lining hostile to pregnancy. Women who have Asherman Syndrome frequently experience repeated miscarriages due to the inability of the uterine lining to support an expanding embryo. Some women may be unable to conceive due to limited space within the uterus or due to concentrated scar tissue.
To reduce the risk of Asherman Syndrome, consider the following:
Asherman's syndrome is a rare but treatable condition. Knowledge of the causes, symptoms, and potential treatments for Asherman's syndrome will empower women to get adequate medical care at the proper time, thus safeguarding their reproductive health. By utilising advanced diagnostic technology and receiving expert advice from Indira IVF's medical professionals, women may seek timely intervention that will restore normal uterine function and increase the likelihood of successful conception.
Asherman’s Syndrome is considered rare. According to the International Asherman’s Association, it affects approximately 1.5% of women undergoing hysterosalpingography (HSG).
There is a risk of adhesion recurrence, particularly in severe cases. To minimise this risk, post-treatment care is provided, which often includes hormone therapy. Regular follow-up hysteroscopies to monitor the uterine cavity and address any new adhesions promptly.
Yes, hysteroscopy is considered the safest method for removing intrauterine scar tissue.
Yes, many women can conceive after proper treatment. Mild cases often respond well to hysteroscopic surgery.
The classic triad includes: Amenorrhea or very light periods, Cyclic pelvic pain, and Infertility. These symptoms typically follow a uterine procedure such as D&C.
Full recovery typically takes 4–6 weeks.